col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


22 Results       Page 1

 [1] 
ECO-Vector: HERALD of North-Western State Medical University named after I I Mechnikov
  original article Date Title Authors   All Authors
1 [GO] 2026―May―26 Air leak syndrome in patients with a new Coronavirus infection. Pathogenetic, clinical, laboratory, and instrumental features Karina E. Borta, Konstantin V. Medvedev, Nikolay Y. Kokhanenko, Nikolay I. Glushkov, Vsevolod А. Zinserling, Natalia Y. Semenova
2 [GO] 2025―Jul―30 Diagnosis and management of cerebral venous and sinus thrombosis in patients recovering from COVID-19 Elena G. Klocheva, Farahnoz Z. Olimova, Mariya Viktorova Zhukova, Inga V. Chistova, Vitalii V. Goldobin
3 [GO] 2024―Dec―20 The experience of using succinate-containing crystalloid solution in the correction of COVID-19-associated endotheliopathy Olga V. Nikolaeva, Ionas S. Simutis, Vyacheslav A. Ratnikov, Alexey N. Scheglov, Larisa B. Gaykovaya, Tatyana P. Zavyalova
4 [GO] 2024―Nov―06 Features of acute coronary syndrome after a COVID-19 in the aspect of pulmonary hypertension Giorgi Dularidze, Sergey A. Saiganov, Igor N. Kochanov, Viktoriya V. Sklyarova, Taras Ya. Burak, Aleksandr L. Kaledin
5 [GO] 2024―Jul―03 Clinical cases of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA vasculitis) induced by COVID-19 Olga V. Mashkunova, Vadim I. Mazurov
6 [GO] 2024―Apr―26 Electrocardiographic signs of cardiovascular system dysfunction in the context of various courses of COVID-19 in young and middle-aged individuals Ekaterina S. Bratilova, Vasilii A. Kachnov, Vadim V. Tyrenko
7 [GO] 2024―Jan―13 The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies Anna Yu. Anisenkova, Vadim I. Mazurov, Svetlana V. Apalko, Oleg S. Popov, Natalya N. Sushentseva, Olga P. Mamaeva, et al. (+3)
8 [GO] 2023―Dec―14 Percutaneous coronary intervention in patients admitted with acute coronary syndrome within 6 months after COVID-19 (retrospective single-center study) Giorgi Dularidze, Sergey A. Sayganov, Igor N. Kochanov, Viktoriya V. Sklyarova
9 [GO] 2023―Jul―28 Comparative analysis of the course of COVID-19 and post-COVID syndrome in patients with inflammatory bowel disease and COVID-19 caused by the Omicron strain and earlier strains Luciya M. Kupkenova, Alfiya Kh. Odintsova, Dilyara G. Iskhakova, Natalya A. Cheremina, Diana I. Abdulganieva
10 [GO] 2022―Nov―17 Clinical, laboratory and instrumental predictors of the effectiveness of anti-inflammatory therapy in COVID-19 Irina M. Sukhomlinova, Igor G. Bakulin, Maxim Yu. Kabanov
11 [GO] 2022―Nov―17 The role of redox status in platelet dysfunction in severe COVID-19-associated pneumonia Mikhail V. Osikov, Vladimir N. Antonov, Semen O. Zotov, Galina L. Ignatova
12 [GO] 2022―Nov―17 Problems associated with new coronavirus infection vaccination in patients with rheumatic diseases Vadim I. Mazurov, Evgeny L. Nasonov, Aleksander M. Lila, Inna Z. Gaydukova, Oksana V. Inamova, Natalia Yu. Leonchenkova
13 [GO] 2022―Jun―17 Anti-inflammatory therapy for COVID-19: effectiveness and predictors of response Irina M. Sukhomlinova, Igor G. Bakulin, Maxim Yu. Kabanov
14 [GO] 2022―Jun―17 Clinical and genetic predictors of cardiovascular events as the risk of an unfavorable course and outcomes of novel coronavirus infection Ekaterina S. Bratilova, Vasilii A. Kachnov, Vadim V. Tyrenko, Svetlana N. Kolyubaeva
15 [GO] 2022―Jun―17 Liver injury and novel coronavirus infection: development mechanisms and clinical manifestation Maria A. Livzan, Olga V. Gaus, Darya A. Gavrilenko
16 [GO] 2021―Aug―30 Impact of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases Vadim I. Mazurov, Irina B. Belyaeva, Lubov E. Sarantseva, Anton L. Chudinov, Roman A. Bashkinov, Evgeni A. Trofimov, et al. (+4)
17 [GO] 2021―Jun―08 Therapeutic potential of the stromal vascular fraction in COVID-19 Valentin N. Pavlov, Albert A. Kazikhinurov, Rustem A. Kazikhinurov, Murad A. Agaverdiyev, Ilgiz F. Gareev, Ozal A. Beylerli, Bakhodur Z. Mazorov
18 [GO] 2021―Jun―08 Prognostic value of cytokines in COVID-19 associated pneumonia Olga Yu. Tkachenko, Margarita Yu. Pervakova, Sergey V. Lapin, Aleksandra V. Mazing, Darya A. Kuznetsova, Anna N. Moshnikova, et al. (+16)
19 [GO] 2021―Jun―08 Major predictive risk factors for cytokine storm in COVID-19 patients (Clinical trials) Anna Yu. Anisenkova, Svetlana V. Apalko, Zakhar P. Asaulenko, Aleksandr N. Bogdanov, Dmitriy A. Vologzhanin, Evgenii Yu. Garbuzov, et al. (+8)
20 [GO] 2021―Mar―22 Possibilities of janus kinase inhibitors application in complex treatment of patients with COVID-19 Sergei A. Saiganov, Vadim I. Mazurov, Evgenii S. Melnikov, Elgudzha L. Latariia
21 [GO] 2020―Aug―22 Current, effectiveness of therapy and outcomes of new coronavirus infection: preliminary analysis Sergey A. Sayganov, Vadim I. Mazurov, Igor G. Bakulin, Elguja L. Lataria, S A Artyushkin, Olga Yu. Chizhova, et al. (+13)
22 [GO] 2020―May―29 Inflammatory bowel diseases during the coronavirus pandemic: potential risks and ways to reduce them Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva, Maria S. Zhuravleva
 [1] 

22 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec